ELV vs XERS · P/E 18, rev $199.13B vs rev $175.2M
Elevance Health Inc (ELV) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. XERS currently screens at market cap $760.7M.
Not investment advice. Open the ELV and XERS stock pages for the full models.
Not investment advice.